Erythroid marrow activity and hemoglobin H levels in hemoglobin H disease

Journal of Pediatric Hematology/Oncology

Volumn 20, Issue 6, 1998, Pages 539-544

  Papassotiriou, Ioannis ^a   Traeger Synodinos, Joanne ^a   Kanavakis, Emmanuel ^a   Karagiorga, Markissia ^a   Stamoulakatou, Alexandra ^a   Kattamis, Christos ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Erythropoiesis; Erythropoietin; HbH disease; Soluble transferrin receptors

Indexed keywords

ALPHA GLOBIN; ERYTHROPOIETIN; HEMOGLOBIN H; TRANSFERRIN RECEPTOR;

ADOLESCENT; ALPHA THALASSEMIA; ARTICLE; BONE MARROW; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; ERYTHROPOIESIS; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEMOGLOBIN DETERMINATION; HEMOGLOBIN H DISEASE; HEMOGLOBINOPATHY; HEMOLYSIS; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT;

EID: 0032450603     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-199811000-00005     Document Type: Article

References (23)

1. Beguin Y, Clemons GK, Pootrakul P, et al. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 1993;81:1067-76.
2. Thorstensen K, Romslo I. The transferrin receptor: its diagnostic value and its potential as therapeutic target. Scand J Clin Lab Invest 1993;53 (Suppl 215):113-20.
3. Kattamis C, Tzotzos S, Kanavakis E, et al. Correlation of clinical phenotype to genotype in HbH disease. Lancet 1988;1:442-4.
4. Wallach J. Interpretation of diagnostic tests, 5th ed. Boston, MA: Little, Brown and Co., 1992:270.
5. Papassotiriou I, Vlachou K, Stamoulakatou A, et al. Accurate quantitation of HbH with cation-exchange HPLC. Br J Haematol 1996;93 (Suppl 2):33.
6. Old J, Higgs D. Gene analysis. In: Methods in hematology: the thalassemias. London: Churchill Livingstone, 1983:74-102.
7. Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
8. Kanavakis E, Tzotzos S, Liapaki A, et al. Frequency of α-thalassemia in Greece. Am J Hematol 1986;22:225-32.
9. Traeger-Synodinos J, Kanavakis E, Vrettou C, et al. The triplicated alpha globin gene locus in β-thalassemia heterozygotes: clinical, hematological, biosynthetic and molecular studies. Br J Haematol 1996;95:467-71.
10. Harteveld K, Heister A, Giordano P, et al. Rapid detection of point mutations and polymorphisms of the α-globin genes by DGGE and SSCA. Hum Mutat 1996;7:114-22.
11. Siggaard-Andersen O, Wimberley P. Oxygen parameters in the presence of HbH. Pediatr Hematol Oncol 1997;14:295-7.
12. Rhyner K, Egli F, Niemoeller M, et al. Serumerythropoietinwerte bei verschiedenen Krankheitszustaenden. Nephron 1989;51: 39-46.
13. Papassotiriou I, Kanavakis E, Stamoulakatou A, et al. Tissue oxygenation in patients with hemoglobinopathy H. Pediatr Hematol Oncol 1997;14:323-34.
14. Papassotiriou I, Kister J, Griffon N, et al. Synthesized allosteric effectors of hemoglobin molecule: a possible mechanism for improved red cells oxygen release capability in hemoglobinopathy H disease. Exp Hematol 1998;26:922-6.
15. Weatherall DJ, Clegg JB. The thalassaemia syndromes, 3rd ed. Oxford, UK: Blackwell Scientific, 1981:529-36.
16. Punnonen K, Irjala K, Rajamaki A. Serum Transferrin Receptor and its ratio to serum Ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052-7.
17. Suominen P, Punnonen K, Rajamaki A, et al. Evaluation of new immunoenzymatic assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin Chem 1997;43:1641-6.
18. Galanello R, Barella S, Turco M, et al. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin β-thalassemia intermedia patients. Blood 1994;83:561-5.
19. Nisli G, Kavakli K, Aydinok Y, et al. Serum eythropoietin levels in patients with beta thalassemia major and intermedia. Pediatr Hematol Oncol 1997;14:161-7.
20. Sherwood J, Goldwasser E, Chilicote R, et al. Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 1986;67:46-9.
21. Ho J, Wickramasinghe N, Rees D, et al. Erythroblastic inclusions in dominantly inherited β-thalassemias. Blood 1997;89:322-8.
22. Singhal A, Cook J, Skikne B, et al. The clinical significance of serum transferrin receptor levels in sickle cell disease. Br J Haematol 1993;84:301-4.
23. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992;80:278-84.